Insmed valuation

INSM · NASDAQ · USD

Compare Insmed
$121.86Change from previous close: −0.83%Absolute change: −$1.02

Close · November 17, 2026

Valuation

The average price target of 22 analysts is $194.18.

Data as of November 17, 2026

Insmed compared with similar companies

Insmed's Forward P/E: 186.7, +1,090% against the median of a group of 8 similar companies (15.7).

Insmed's metrics compared with similar companies
MetricInsmedMedian25th–75th percentileBand
Forward P/E186.715.713.4 – 26.9High
Price/book37.17.124.45 – 9.96High
Price/sales17.77.994.99 – 15.2High
Gross margin84.4%84.4%66.4% – 91.5%Middle
Operating margin-41.7%19.5%-48.6% – 31.6%Middle
Net margin-39.9%6.7%0.0% – 30.6%Low
ROE-72.5%7.8%-8.3% – 31.4%Low
Debt/equity1.010.350.06 – 0.85High

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$26.96B
Enterprise value
$26.54B
PEG
1.09
EV/EBITDA
-43.4
EV/revenue
17.5

Profitability and growth

ROA
-17.3%
Revenue growth (year over year)
268.4%

Financial health

Total cash
$1.15B
Total debt
$730.94M
Current ratio
2.86
Quick ratio
2.36

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$194.18
Median price target
$195.00
High price target
$243.00
Low price target
$158.00
Analysts with a price target
22
Consensus
Strong buy
Forward EPS
$0.66
EPS estimate, current year
-$1.67

Shares and trading

Beta
0.81
Average volume
2.78M
Shares outstanding
219.38M
Float
217.93M
Institutional ownership
104.5%
Insider ownership
1.0%
Short interest (% of float)
7.2%
Short ratio (days)
3.83